Relatively new to the drug market, Beovu® (brolucizumab) was approved by the U.S. Food and Drug Administration (FDA) in 2019 to treat age-related macular degeneration,…
Personal Injury Lawyers Serving the Entire U.S.
Relatively new to the drug market, Beovu® (brolucizumab) was approved by the U.S. Food and Drug Administration (FDA) in 2019 to treat age-related macular degeneration,…
The only known medical treatment for interstitial cystitis (IC) is increasingly linked to severe vision problems in patients who use the drug. The drug is…
Hello, we're sorry to barge in, but we are available to answer your questions.
Would you like to speak to a live person?